OBJECTIVE: To identify the incidence and clinical significance of myocardial injury following elective stent implantation. DESIGN: Prospective clinical study with 278 consecutive patients undergoing stenting of de novo coronary or saphenous vein graft lesions. Incidence of periprocedural myocardial injury was assessed by analysis of 12 lead ECG, creatine kinase (CK; upper limit of normal (ULN) 70 IU/l for women, 80 IU/l for men), and cardiac troponin T (cTnT; point of care test; threshold 0.1 ng/ml) before and 6, 12, and 24 hours after the intervention. Major adverse cardiac events (MACE: acute myocardial infarction, bypass surgery, and cardiac death) were recorded during clinical follow up (mean (SD) 7.8 (5.3) months). RESULTS: Following elective stenting, the rate of a positive cTnT status was 17.3%, the rate of CK increase of 1-3x ULN 14.7%, the rate of CK increase of > 3x ULN 1.4%, and the rate of Q wave myocardial infarction 0.4%. Cardiac mortality during follow up was higher in patients with postprocedurally increased CK (7.1% v 1.3%, p = 0.01, log rank) and cTnT (9.1% v 0.9%, p < 0.001, log rank). In addition, postprocedurally increased cTnT was associated with a higher overall incidence of MACE (13.1% v 4.0%, p < 0.01, log rank) and was identified as an independent factor for MACE during follow up (hazard ratio 3.27, 95% confidence interval 1.14 to 9.41, p = 0.028). CONCLUSIONS: Following elective stent implantation, a positive cTnT status identified patients at risk of a worse long term outcome. Treatment strategies have to be developed that lead to prognostic improvement by reducing periprocedural myocardial injury.
OBJECTIVE: To identify the incidence and clinical significance of myocardial injury following elective stent implantation. DESIGN: Prospective clinical study with 278 consecutive patients undergoing stenting of de novo coronary or saphenous vein graft lesions. Incidence of periprocedural myocardial injury was assessed by analysis of 12 lead ECG, creatine kinase (CK; upper limit of normal (ULN) 70 IU/l for women, 80 IU/l for men), and cardiac troponin T (cTnT; point of care test; threshold 0.1 ng/ml) before and 6, 12, and 24 hours after the intervention. Major adverse cardiac events (MACE: acute myocardial infarction, bypass surgery, and cardiac death) were recorded during clinical follow up (mean (SD) 7.8 (5.3) months). RESULTS: Following elective stenting, the rate of a positive cTnT status was 17.3%, the rate of CK increase of 1-3x ULN 14.7%, the rate of CK increase of > 3x ULN 1.4%, and the rate of Q wave myocardial infarction 0.4%. Cardiac mortality during follow up was higher in patients with postprocedurally increased CK (7.1% v 1.3%, p = 0.01, log rank) and cTnT (9.1% v 0.9%, p < 0.001, log rank). In addition, postprocedurally increased cTnT was associated with a higher overall incidence of MACE (13.1% v 4.0%, p < 0.01, log rank) and was identified as an independent factor for MACE during follow up (hazard ratio 3.27, 95% confidence interval 1.14 to 9.41, p = 0.028). CONCLUSIONS: Following elective stent implantation, a positive cTnT status identified patients at risk of a worse long term outcome. Treatment strategies have to be developed that lead to prognostic improvement by reducing periprocedural myocardial injury.
Authors: M M Hirschl; H Herkner; A N Laggner; C Sylvén; G Rasmanis; P O Collinson; W Gerhardt; R Leinberger; R Zerback; M Müller-Bardorff; H A Katus Journal: Arch Pathol Lab Med Date: 2000-04 Impact factor: 5.534
Authors: C Briguori; I Sheiban; J De Gregorio; A Anzuini; M Montorfano; P Pagnotta; F Marsico; F Leonardo; C Di Mario; A Colombo Journal: J Am Coll Cardiol Date: 1999-12 Impact factor: 24.094
Authors: R Mehran; G Dangas; G S Mintz; A J Lansky; A D Pichard; L F Satler; K M Kent; G W Stone; M B Leon Journal: Circulation Date: 2000-02-15 Impact factor: 29.690
Authors: J F Saucedo; R Mehran; G Dangas; M K Hong; A Lansky; K M Kent; L F Satler; A D Pichard; G W Stone; M B Leon Journal: J Am Coll Cardiol Date: 2000-04 Impact factor: 24.094
Authors: A Kini; J D Marmur; S Kini; G Dangas; T P Cocke; S Wallenstein; E Brown; J A Ambrose; S K Sharma Journal: J Am Coll Cardiol Date: 1999-09 Impact factor: 24.094
Authors: J A J M Hermens; G K van Houwelingen; F H A F de Man; H W Louwerenburg; C von Birgelen Journal: Neth Heart J Date: 2010-09 Impact factor: 2.380
Authors: Josef Veselka; Sárka Procházková; Radka Duchonová; Ingrid Homolová; David Tesar; Kevin A Bybee Journal: Heart Vessels Date: 2006-05 Impact factor: 2.037
Authors: Jaroslav Hubacek; Rashpal S Basran; Fiona M Shrive; Lana Shewchuk; David M Goodhart; Todd J Anderson Journal: Can J Cardiol Date: 2009-02 Impact factor: 5.223
Authors: Olivier Gach; Olivier Louis; Jean Paul Chapelle; Sophie Vanbelle; Luc A Pierard; Victor Legrand Journal: Heart Vessels Date: 2009-07-22 Impact factor: 2.037